Aimcare

We’re excited to share that we’ve been selected as part of the second cohort of the Investing in Innovation (i3 program).

It's an incredible opportunity to be chosen among the top 29 startups across Africa. We're grateful to the i3 selection committees, Bill & Melinda Gates Foundation, Cencora (formerly AmerisourceBergen), Merck Sharp & Dohme (MSD), Microsoft and Chemonics for believing in our mission.

Our team looks forward to receiving access to market opportunities to foster growth-focused partnerships, investment readiness support, and a $50,000 grant to help us grow and make a meaningful impact.

We can't wait to participate in the Access to Market event in Nairobi this November 💥.

The African healthcare market will be worth $259B by 2030, with the continent presenting 14% of health and well-being business opportunities, only second to North America with 21%.

If you’ve a medical device or consumable fit for this market, you should talk to us.

At Aimcare, we create distribution channels for medical devices & pharmaceutical products manufacturers in Europe & Asia.

This means we have to translate business goals of companies 5,000 miles away into results here. 7,000+ units sold for our Czech partners in 6 mo. Excited!

Let’s work together!

Happy new year 🥳 🥳🥳🎉. Wishing you an amazing year ahead!!!